論文 |
papers |
-
Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases. Tosin Oladipo Afowowe,Yasuteru Sakurai,Shuzo Urata,Vahid Rajabali Zadeh,Jiro Yasuda Viruses 15巻1号 2022年12月30日
-
Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2 Mya Myat Ngwe Tun,Takaya Sakura,Yasuteru Sakurai,Yohei Kurosaki,Daniel Ken Inaoka,Norifumi Shioda,Jiro Yasuda,Kiyoshi Kita,Kouichi Morita Tropical Medicine and Health 50巻1号 2022年12月
-
5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro Mya Myat Ngwe Tun,Takaya Sakura,Yasuteru Sakurai,Yohei Kurosaki,Daniel Ken Inaoka,Norifumi Shioda,Chris Smith,Jiro Yasuda,Kouichi Morita,Kiyoshi Kita Tropical Medicine and Health 50巻1号 2022年12月
-
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus. Minato Hirano,Yasuteru Sakurai,Shuzo Urata,Yohei Kurosaki,Jiro Yasuda,Kentaro Yoshii Antiviral research 200巻105276頁-105276頁 2022年04月
-
Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors. Benedicte Mpia Moni,Yasuteru Sakurai,Jiro Yasuda Viruses 14巻1号 2022年01月13日
-
Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan. Haruka Abe,Yuri Ushijima,Murasaki Amano,Yasuteru Sakurai,Rokusuke Yoshikawa,Takaaki Kinoshita,Yohei Kurosaki,Katsunori Yanagihara,Koichi Izumikawa,Kouichi Morita,Shigeru Kohno,Jiro Yasuda Microorganisms 10巻1号 2022年01月04日
-
Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Takaaki Kinoshita,Kenichi Watanabe,Yasuteru Sakurai,Kodai Nishi,Rokusuke Yoshikawa,Jiro Yasuda Scientific reports 11巻1号21259頁-21259頁 2021年10月28日
-
iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility. Keiko Imamura,Yasuteru Sakurai,Takako Enami,Ran Shibukawa,Yohei Nishi,Akira Ohta,Tsugumine Shu,Jitsutaro Kawaguchi,Sayaka Okada,Thomas Hoenen,Jiro Yasuda,Haruhisa Inoue FEBS open bio 11巻5号1452頁-1464頁 2021年05月
-
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro Yasuteru Sakurai,Mya Myat Ngwe Tun,Yohei Kurosaki,Takaya Sakura,Daniel Ken Inaoka,Kiyotaka Fujine,Kiyoshi Kita,Kouichi Morita,Jiro Yasuda Biochemical and Biophysical Research Communications 545巻203頁-207頁 2021年01月
-
Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants. Akitsu Masuda,Jae Man Lee,Takeshi Miyata,Hiroaki Mon,Keita Sato,Kosuke Oyama,Yasuteru Sakurai,Jiro Yasuda,Daisuke Takahashi,Tadashi Ueda,Yuri Kato,Motohiro Nishida,Noriko Karasaki,Kohei Kakino,Takeru Ebihara,Takumi Nagasato,Masato Hino,Ayaka Nakashima,Kengo Suzuki,Yoshino Tonooka,Miyu Tanaka,Takato Moriyama,Hirokazu Nakatake,Ryosuke Fujita,Takahiro Kusakabe Frontiers in immunology 12巻803647頁-803647頁 2021年
-
Topoisomerase II as a Novel Antiviral Target against Panarenaviral Diseases. Tosin Oladipo Afowowe,Yasuteru Sakurai,Shuzo Urata,Vahid Rajabali Zadeh,Jiro Yasuda Viruses 15.1. 2022/12/30
-
Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2 Mya Myat Ngwe Tun,Takaya Sakura,Yasuteru Sakurai,Yohei Kurosaki,Daniel Ken Inaoka,Norifumi Shioda,Jiro Yasuda,Kiyoshi Kita,Kouichi Morita Tropical Medicine and Health 50.1. 2022/12
-
5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro Mya Myat Ngwe Tun,Takaya Sakura,Yasuteru Sakurai,Yohei Kurosaki,Daniel Ken Inaoka,Norifumi Shioda,Chris Smith,Jiro Yasuda,Kouichi Morita,Kiyoshi Kita Tropical Medicine and Health 50.1. 2022/12
-
A screen of FDA-approved drugs with minigenome identified tigecycline as an antiviral targeting nucleoprotein of Crimean-Congo hemorrhagic fever virus. Minato Hirano,Yasuteru Sakurai,Shuzo Urata,Yohei Kurosaki,Jiro Yasuda,Kentaro Yoshii Antiviral research 200.105276-105276 2022/04
-
Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors. Benedicte Mpia Moni,Yasuteru Sakurai,Jiro Yasuda Viruses 14.1. 2022/01/13
-
Unique Evolution of SARS-CoV-2 in the Second Large Cruise Ship Cluster in Japan. Haruka Abe,Yuri Ushijima,Murasaki Amano,Yasuteru Sakurai,Rokusuke Yoshikawa,Takaaki Kinoshita,Yohei Kurosaki,Katsunori Yanagihara,Koichi Izumikawa,Kouichi Morita,Shigeru Kohno,Jiro Yasuda Microorganisms 10.1. 2022/01/04
-
Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Takaaki Kinoshita,Kenichi Watanabe,Yasuteru Sakurai,Kodai Nishi,Rokusuke Yoshikawa,Jiro Yasuda Scientific reports 11.1.21259-21259 2021/10/28
-
iPSC screening for drug repurposing identifies anti-RNA virus agents modulating host cell susceptibility. Keiko Imamura,Yasuteru Sakurai,Takako Enami,Ran Shibukawa,Yohei Nishi,Akira Ohta,Tsugumine Shu,Jitsutaro Kawaguchi,Sayaka Okada,Thomas Hoenen,Jiro Yasuda,Haruhisa Inoue FEBS open bio 11.5.1452-1464 2021/05
-
5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro Yasuteru Sakurai,Mya Myat Ngwe Tun,Yohei Kurosaki,Takaya Sakura,Daniel Ken Inaoka,Kiyotaka Fujine,Kiyoshi Kita,Kouichi Morita,Jiro Yasuda Biochemical and Biophysical Research Communications 545.203-207 2021/01
-
Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants. Akitsu Masuda,Jae Man Lee,Takeshi Miyata,Hiroaki Mon,Keita Sato,Kosuke Oyama,Yasuteru Sakurai,Jiro Yasuda,Daisuke Takahashi,Tadashi Ueda,Yuri Kato,Motohiro Nishida,Noriko Karasaki,Kohei Kakino,Takeru Ebihara,Takumi Nagasato,Masato Hino,Ayaka Nakashima,Kengo Suzuki,Yoshino Tonooka,Miyu Tanaka,Takato Moriyama,Hirokazu Nakatake,Ryosuke Fujita,Takahiro Kusakabe Frontiers in immunology 12.803647-803647 2021
|